Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06061952 · ClinicalTrials.gov registry record · NA
CAE for Poorly Adherent Individuals With Schizophrenia
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT06061952 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 36 participants.
The verdict
NCT06061952, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This project aims to evaluate the feasibility, acceptability and preliminary efficacy of remotely delivered CAE among patients with schizophrenia (CAE-S).
Interventions
- BEHAVIORAL Customized Adherence Enhancement for Schizophrenia (CAE-S)
- OTHER Enhanced Treatment as Usual (eTAU)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-01-16 |
| Est. Completion | 2025-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06061952
The ClinicalTrials.gov registry entry for NCT06061952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Customized Adherence Enhancement for Schizophrenia (CAE-S) is the first listed.
NCT06061952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06061952 about?
NCT06061952 is a clinical study titled "CAE for Poorly Adherent Individuals With Schizophrenia". This project aims to evaluate the feasibility, acceptability and preliminary efficacy of remotely delivered CAE among patients with schizophrenia (CAE-S).
What is the current status of trial NCT06061952?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2024-01-16. Estimated completion is 2025-08-09.
What interventions are being tested in trial NCT06061952?
The interventions under investigation include: Customized Adherence Enhancement for Schizophrenia (CAE-S) (BEHAVIORAL), Enhanced Treatment as Usual (eTAU) (OTHER).
Who is sponsoring clinical trial NCT06061952?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.